A novel facile method of labeling octreotide with18F-fluorine

Journal of Nuclear Medicine

Volumn 51, Issue 3, 2010, Pages 454-461

  Laverman, Peter ^a   McBride, William J ^b   Sharkey, Robert M ^c   Eek, Annemarie ^a   Joosten, Lieke ^a   Oyen, Wim J G ^a   Goldenberg, David M ^c   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b IMMUNOMEDICS INC   (United States)

^c CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

Author keywords

Aluminum fluoride; NOTA; Octreotide; Peptide; PET; Radiofluorination

Indexed keywords

1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID PHENYLALANYL CYCLO[CYSTEINYLPHENYLALANYLTRYPTOPHYLLYSYLTHREONYLCYSTEINE]THROL; 2 MORPHOLINOETHANESULFONIC ACID; 4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; ACETIC ACID; ALUMINUM FLUORIDE; CITRATE SODIUM; FLUORINE 18; GALLIUM 68; OCTANOL; OCTREOTIDE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; WATER; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; 1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID; ALUMINUM CHLORIDE; ALUMINUM DERIVATIVE; BUFFER; CHLORIDE; DRUG DERIVATIVE; FLUORINE; HETEROCYCLIC COMPOUND; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHELATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG STABILITY; GENE EXPRESSION REGULATION; GENETICS; HALOGENATION; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; TIME; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ALUMINUM COMPOUNDS; AMINO ACID SEQUENCE; ANIMALS; BUFFERS; CELL LINE, TUMOR; CHLORIDES; DRUG STABILITY; FLUORINE RADIOISOTOPES; GENE EXPRESSION REGULATION, NEOPLASTIC; HALOGENATION; HETEROCYCLIC COMPOUNDS; HUMANS; INHIBITORY CONCENTRATION 50; ISOTOPE LABELING; MALE; MICE; NEOPLASMS; OCTANOLS; OCTREOTIDE; RATS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TIME FACTORS; TISSUE DISTRIBUTION; WATER;

EID: 77950348936     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.066902     Document Type: Article

References (20)

1. Visser EP, Disselhorst JA, Brom M, et al. Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J Nucl Med. 2009;50:139-147.
2. 18F]-N-succinimidyl 4-(fluoromethyl) benzoate for protein labeling. Appl Radiat Isot. 1994;45:1155-1163.
3. 18F-labeled RGD and octreotide analogs. J Nucl Med. 2004;45:892-902.
4. Rennen HJ, Laverman P, van Eerd JE, Oyen WJ, Corstens FH, Boerman OC. PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation. Nucl Med Biol. 2007;34:691-695. (Pubitemid 47248281)
5. Schottelius M, Poethko T, Herz M, et al. First 18F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Clin Cancer Res. 2004;10:3593-3606. (Pubitemid 38697592)
6. 18F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK). Eur J Nucl Med Mol Imaging. 2009;36:1469-1474.
7. 18F]FDG. Bioconjug Chem. 2009;2009;20:432-436.
8. Glaser M, Arstad E. "Click labeling" with 2-[18f] fluoroethylazide for positron emission tomography. Bioconjug Chem. 2007;18:989-993.
9. 18F]fluoropropionyl-peptides. J Med Chem. 2008;51: 5901-5904.
10. Marik J, Sutcliffe JL. Click for PET: rapid preparation of [F-18]fluoropeptides using Cu-I catalyzed 1,3-dipolar cycloaddition. Tetrahedron Lett. 2006;47:6681-6684. (Pubitemid 44176106)
11. 3 expression. Bioconjug Chem. 2007;18:1987-1994.
12. 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks. Bioconjug Chem. 2008;19:1871-1879.
13. 18F-radiolabeling of peptides for PET imaging. Angew Chem Int Ed Engl. 2008;47:4922-4925.
14. 18F radiolabeling for PET. J Nucl Med. 2009;50:991-998.
15. Reubi JC, Schar JC, Waser B, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med. 2000;27:273-282. (Pubitemid 30167697)
16. 68Ga-based PET-radiopharmaceuticals at room temperature. Bioconjug Chem. 2008;19:569-573.
17. Martin RB. Ternary hydroxide complexes in neutral solutions of Al3+ and F-. Biochem Biophys Res Commun. 1988;155:1194-1200.
18. Antunes P, Ginj M, Walter MA, Chen J, Reubi JC, Maecke HR. Influence of different spacers on the biological profile of a DOTA-somatostatin analogue. Bioconjug Chem. 2007;18:84-92. (Pubitemid 46145997)
19. 18F-labelled, carbohydrated analogue of octreotide. Eur J Nucl Med Mol Imaging. 2003;30:117-122.
20. 18F] fluoropropionyl-(D)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice. Nucl Med Biol. 1994;21:819-825.